MarketPeel
Insider Trading Intelligence
Pricing
…
BR

Brian Kenneth Roberts

RZLT
CHIEF MEDICAL OFFICER · REZOLUTE, INC. · CIK 0001829608
FILING MIX · LIFETIME87%/13%
BUYS
27
SELLS
4
TOTAL VALUE
$287.4K
COMPANIES
1
ACTIVE SINCE
Jun 2021
HOLDINGS NOW
293,851
AVG SELL PX
$3.41
TRADE KIND
SHOWING 31 / 31
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
18 backtested trades · 8 horizons · 3 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Brian Kenneth Roberts, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d18+55.56%+7.60%+0.11%+7.49%+2.10%—
14d18+77.78%+16.78%+1.16%+15.62%+8.27%—
30d18+88.89%+21.76%+0.58%+21.18%+20.31%—
60d18+88.89%+42.51%+0.23%+42.28%+45.12%—
90d18+88.89%+60.45%+4.75%+55.70%+32.02%—
180d18+72.22%+57.02%+8.29%+48.74%+30.63%—
1y18(1 pending)+76.47%+43.69%+11.81%+31.88%-5.06%—
2y18(2 pending)+50.00%+28.65%+35.57%-6.92%-36.39%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RZLT · 293,851 shares · as of Jul 2, 2026
0175,000350,000525,000700,00020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 27 buys / 4 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RZLT
REZOLUTE, INC.
SALE
Chief Medical Officer
3,062$4.99$15.3K293,851Jul 2, 2026Jul 7, 2026 ↗View →
RZLT
REZOLUTE, INC.
SALE
Chief Medical Officer
11,439$2.99$34.2K296,913Mar 2, 2026Mar 4, 2026 ↗View →
RZLT
REZOLUTE, INC.
PURCHASE
Chief Medical Officer
28,000$1.70$47.6K308,352Dec 16, 2025Dec 17, 2025 ↗View →
RZLT
REZOLUTE, INC.
PURCHASEGRANT
Stock grant
123,000——280,352Nov 19, 2025Nov 21, 2025 ↗View →
RZLT
REZOLUTE, INC.
PURCHASE
Chief Medical Officer
2,500$4.38$10.9K15,500Jun 25, 2025Jun 25, 2025 ↗View →
RZLT
REZOLUTE, INC.
PURCHASEGRANT
Stock grant
26,000——157,352Jun 10, 2025Jun 12, 2025 ↗View →
RZLT
REZOLUTE, INC.
PURCHASEGRANT
Stock grant
15,000——15,000Jun 10, 2025Jun 12, 2025 ↗View →
RZLT
REZOLUTE, INC.
PURCHASEGRANT
Stock grant
77,000——131,352Feb 16, 2025Feb 19, 2025 ↗View →
RZLT
REZOLUTE, INC.
PURCHASEGRANT
Stock grant
45,000——45,000Feb 16, 2025Feb 19, 2025 ↗View →
RZLT
REZOLUTE, INC.
PURCHASE
Chief Medical Officer
3,000$3.91$11.7K13,000Jun 14, 2024Jun 14, 2024 ↗View →
RZLT
REZOLUTE, INC.
PURCHASE
Chief Medical Officer
4,000$3.91$15.6K54,052Jun 14, 2024Jun 14, 2024 ↗View →
RZLT
REZOLUTE, INC.
PURCHASE
Chief Medical Officer
300$3.96$1.2K54,352Jun 14, 2024Jun 14, 2024 ↗View →
RZLT
REZOLUTE, INC.
PURCHASE
Chief Medical Officer
300$3.97$1.2K1,376Jun 14, 2024Jun 14, 2024 ↗View →
RZLT
REZOLUTE, INC.
PURCHASE
Chief Medical Officer
6,000$2.68$16.1K50,052May 23, 2024May 28, 2024 ↗View →
RZLT
REZOLUTE, INC.
PURCHASE
Chief Medical Officer
1,500$2.72$4.1K44,052May 23, 2024May 28, 2024 ↗View →
RZLT
REZOLUTE, INC.
PURCHASE
Chief Medical Officer
500$2.55$1.3K1,076Mar 28, 2024Mar 29, 2024 ↗View →
RZLT
REZOLUTE, INC.
PURCHASE
Chief Medical Officer
10,000$1.88$18.8K10,000Mar 14, 2024Mar 15, 2024 ↗View →
RZLT
REZOLUTE, INC.
PURCHASE
Chief Medical Officer
500$1.85$925576Mar 7, 2024Mar 8, 2024 ↗View →
RZLT
REZOLUTE, INC.
PURCHASE
Chief Medical Officer
500$1.85$925500Mar 7, 2024Mar 8, 2024 ↗View →
RZLT
REZOLUTE, INC.
PURCHASE
Chief Medical Officer
2,000$1.70$3.4K42,552Feb 26, 2024Feb 26, 2024 ↗View →
RZLT
REZOLUTE, INC.
PURCHASE
Chief Medical Officer
6,000$1.69$10.1K40,552Feb 23, 2024Feb 26, 2024 ↗View →
RZLT
REZOLUTE, INC.
PURCHASE
Chief Medical Officer
7,000$1.31$9.1K34,552Feb 16, 2024Feb 19, 2024 ↗View →
RZLT
REZOLUTE, INC.
PURCHASEGRANT
Stock grant
130,000——130,000Jan 23, 2024Jan 24, 2024 ↗View →
RZLT
REZOLUTE, INC.
PURCHASEGRANT
Stock grant
700,000——700,000Jun 23, 2022Jun 27, 2022 ↗View →
RZLT
REZOLUTE, INC.
PURCHASE
Sr VP, Clinic Development
300$2.95$88422,552May 19, 2022May 19, 2022 ↗View →
RZLT
REZOLUTE, INC.
PURCHASE
Sr VP, Clinic Development
200$2.86$57222,252May 18, 2022May 19, 2022 ↗View →
RZLT
REZOLUTE, INC.
PURCHASE
Sr VP, Clinic Development
1,000$3.41$3.4K22,052May 17, 2022May 19, 2022 ↗View →
RZLT
REZOLUTE, INC.
PURCHASE
Sr VP, Clinic Development
21,052$3.80$80.0K21,052May 4, 2022May 6, 2022 ↗View →
RZLT
REZOLUTE, INC.
SALE
Sr VP, Clinic Development
9,000——0Jun 14, 2021Jul 14, 2021 ↗View →
RZLT
REZOLUTE, INC.
SALE
Sr VP, Clinic Development
20,000——0Jun 14, 2021Jul 14, 2021 ↗View →
RZLT
REZOLUTE, INC.
PURCHASEGRANT
Stock grant
75,000——75,000Jun 14, 2021Jul 14, 2021 ↗View →
Other insiders · RZLT
Loading peer insiders…
About this filer
CIK 0001829608
ROLE
Chief Medical Officer
PRIMARY
RZLT
COMPANIES
1
ACTIVE SINCE
Jun 2021
MARKETPEEL · /INSIDER/0001829608DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback